EPAZ News $EPAZ Epazz had 3 Straight Quarters of

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
EPAZ News $EPAZ

Epazz had 3 Straight Quarters of Revenue Growth in 2014
ACCESSWIRE - Thu Feb 12, 7:51AM CST
Epazz will integrate its newest acquisition, Strand Live Video software, into its Intellisys Software

Epazz DeskFlex Cloud Renewed 90% of Our Cloud Contracts; Major Product Upgrade has started for DeskFlex to Integrate Cynergy
ACCESSWIRE - Wed Feb 04, 7:49AM CST
Intellisys Cloud Generated Over $50,000 in New Contracts

Epazz: Intellisys Signs Over $50,000 Worth of New Contracts for its New SystemVIEW Cloud Product for January
ACCESSWIRE - Wed Jan 28, 8:14AM CST
SystemVIEW Cloud will allow Intellisys to sell in new Vertical Markets

Epazz Next Spin-Off: Terran Power, Inc. Stock Dividend; Epazz First Spin-Off: FlexFridge, Inc. Files Form-10, One Step Closer to
ACCESSWIRE - Thu Jan 22, 7:53AM CST
CHICAGO, IL / ACCESSWIRE / January 22, 2015 / Epazz, Inc. (OTCQB: EPAZ), a leading provider of cloud-based business software solutions, is announcing that its next spin-off, Terran Power, Inc., is in the process of filing a provisional patent for its mobile power technology, which will make it easier to generate power on the go. Terran Power is a project to develop a mobile power device that allows iPhone and other smartphone users to power up their phones on the go without needing an outlet or a second battery. The smartphone-accessories market is a $20 billion/year market. Once the provisional patent has been filed, Epazz will announce the record date when the Terran Power stock dividend will take place.

Epazz First Spin-Off: FlexFridge, Inc. (Foldable Mini-Fridge) Plans to File Form-10 Today
ACCESSWIRE - Wed Jan 21, 8:02AM CST
FlexFridge, Inc. will Launch a Crowdfunding Campaign for Pre-orderingEpazz Transitioning to Holding Company via Acquisitions & Spin-Off Business Model

Epazz Reports 120 Percent Increase in Assets for Third Quarter of 2014
ACCESSWIRE - Wed Jan 14, 7:52AM CST
CHICAGO, IL / ACCESSWIRE / January 14, 2015 / Epazz, Inc. (OTCQB: EPAZ), a leading provider of cloud based business software solutions announced today that for the quarter ended September 30, 2014 we had assets of $2,382,194 compared to assets of $1,082,961 for the year ended December 31, 2013, an increase of $1,299,233 or 120%. As we acquire other software companies our assets will grow. This is an important qualification to be listed on a stock exchange.

Epazz Reports Positive EBITDA of $26, 613 for third quarter of 2014; Epazz Decreases its Operating Expenses by 32 percent
ACCESSWIRE - Wed Jan 07, 7:48AM CST
CHICAGO, IL / ACCESSWIRE / January 7, 2015 / Epazz, Inc. (OTCQB: EPAZ), a leading provider of cloud-based business software solutions, announced today that it has reported positive EBITDA of $26,613, compared to negative EBITDA of $384,078 for the three months ending September 30, 2014, an increase of $410,691 or 106% from the comparative period. Also the company has reported a decrease in operating expenses for the three months ending September 30, 2014 of $192,566 or 32% from the comparative period.

Epazz Signs Purchase Agreement to Acquire Medical Billing Software Company; Expects to Add $700,000 to Revenue Stream
ACCESSWIRE - Tue Jan 06, 7:44AM CST
CHICAGO, IL / ACCESSWIRE / January 6, 2015 / Epazz, Inc. (OTCQB: EPAZ), a leading provider of cloud based business software solutions announced that the Company has signed a purchase agreement to acquire a Medical Billing Software Company in the West U.S. This new acquisition is expected to provide substantial growth to Epazz's revenue stream by bringing in $700,000 in revenues in the first year. The unaudited revenues for 2014 were over $700,000. This is Epazz's largest acquisition to date.

Epazz Decreases Operating Expenses by 32 Percent While Increasing Revenues by 130 Percent
ACCESSWIRE - Tue Dec 09, 7:33AM CST
Chicago, IL / ACCESSWIRE / December 9, 2014 / Epazz, Inc. (OTCQB: EPAZ), a leading provider of cloud-based business software solutions, announced a decrease in operating expenses for the three months ending September 30, 2014 of $192,566, or 32% from the comparative period. At the same time, Epazz has increased revenues by 130 percent or $361,150 compared to $156,750 in revenues for the three months ending September 30, 2014.

Epazz Reports 130 Percent Increase in Revenues for Third Quarter of 2014
ACCESSWIRE - Tue Dec 02, 8:31AM CST
Image: https://www.accesswire.com/uploads/uzhvwEPZZ.png

Epazz's Acquisitions of Cynergy, Service Desk Software, and Strand, a Surveillance Software Company, Will Create New Revenue
ACCESSWIRE - Tue Nov 18, 2:47AM CST
Epazz expects to add over $400,000 to its revenue stream with the two acquisitions.

Epazz buys Strand
M2 - Wed Nov 05, 8:37AM CST
Epazz, Inc. (OTC: EPAZ) reported it has completed the acquisition of Strand, Inc. a surveillance software company used by US colleges and universities.

Epazz Completes Acquisition of Strand, Inc., Surveillance Software Company, Expects to Add Over $300,000 to Revenue Stream
Marketwired - Tue Nov 04, 7:15AM CST
Epazz, Inc. (OTCQB: EPAZ), a leading provider of cloud-based business software solutions, announced that it has completed the acquisition of Strand, Inc. a surveillance software company used by US colleges and universities. This new acquisition is expected to increase Epazz's revenue stream by generating $300,000 in recurring revenues during the first year.

Epazz seeks uplisting to OTCQB
M2 - Tue Oct 07, 7:47AM CDT
Epazz, Inc. (OTC: EPAZ) said that it has applied for uplisting to the OTCQB.

Epazz Applied for Uplisting to the OTCQB
Marketwire - Mon Oct 06, 8:10AM CDT
Epazz, Inc. (OTC Pink: EPAZ), a leading provider of cloud-based business software solutions announced that it has applied for uplisting to the OTCQB. Otcmarkets made changes to the requirements for OTCQB status, and the company has filed the necessary documents to qualify for uplisting. Recently, the company announced 21% growth of revenue in the first quarter and 17% growth of revenue in the second quarter. Furthermore, the company has announced the completion of the acquisition of Cynergy, helpdesk software. The company believes that OTCQB status will assist in its future growth plans.

Epazz acquires Cynergy
M2 - Mon Oct 06, 7:35AM CDT
Epazz, Inc. (OTC: EPAZ) reported that it has acquired Cynergy, a move the company expects will provide 15 percent growth to its recurring revenue stream.

Epazz Has Completed Acquisition of Cynergy; Epazz Expects to Add 15% to Recurring Revenue Stream
Marketwire - Fri Oct 03, 8:00AM CDT
Epazz, Inc. (PINKSHEETS: EPAZ), a leading provider of cloud-based business software solutions, announced that it has acquired Cynergy. Cynergy Help Desk Software is customer service and technical support solution used by many Fortune 500 companies. Cynergy is expected to provide substantial growth to Epazz's recurring revenue stream by 15%.

Epazz revenue up 17% YoY
M2 - Fri Oct 03, 7:07AM CDT
Epazz Inc. (OTC: EPAZ) said that it has filed the 10-Q for the three months ending June 30, 2014, and has reported revenue of USD327,525, compared to revenue of USD279,119 for the three months ending June 30, 2013, an increase of USD48,406 or 17 percent from the comparative period.

Epazz, Inc. (EPAZ) Stock Research Links

EPAZ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 188

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 178

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 92

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 169

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Oasis Management Proposes Governance Change for Kobayashi Pharma

Updated Category News Views 243

Oasis Management Advocates for Enhanced Governance at Kobayashi Pharma Oasis Management Company Ltd. (“Oasis”) has emerged as a significant voice among shareholders of Kobayashi Pharmaceutical Co., Ltd. (4967 JT). Holding over 7.5% of the company, Oasis is actively pushing for essential changes in leadership and independent oversight to address pressing governance...

Continue Reading
Synopsys Faces Legal Challenges Amid Stockholder Concerns

Updated Category News Views 235

Understanding the Recent Class Action Lawsuit Against Synopsys Recently, concerns have emerged regarding Synopsys, Inc. as a class action lawsuit was filed alleging serious misrepresentations concerning the company’s financial health. Investors who have been affected are encouraged to seek guidance to explore their legal rights and options that may arise from this...

Continue Reading
Cumulus Media's Engaging Coverage of 2025 NCAA Basketball Events

Updated Category News Views 228

Thrilling NCAA Basketball Coverage by Cumulus Media Cumulus Media’s Westwood One is gearing up for an exciting audio experience during the 2025 NCAA Men’s and Women’s Basketball tournaments. With the largest radio network in the country, Westwood One will deliver comprehensive coverage that connects die-hard sports fans across a plethora of platforms. Connecting...

Continue Reading
ByteDance's Ambitious AI Chip Investment Plans for 2025

Updated Category News Views 1644

ByteDance's Strategic Investment in AI Technology ByteDance, the renowned owner of TikTok, is making significant strides in artificial intelligence by planning to invest more than $12 billion on AI infrastructure in the upcoming years. This ambitious investment highlights the company's commitment to harnessing cutting-edge technology for growth. According to reports, the...

Continue Reading
Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit

Updated Category News Views 130

Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit The law firm Robbins Geller Rudman & Dowd LLP is calling for investors of ModivCare, Inc. (NASDAQ: MODV) who have experienced significant financial losses to take action. Understanding the Class Action Lawsuit The upcoming class action lawsuit, titled Kalera v. ModivCare, Inc., brings serious allegations...

Continue Reading